AstraZeneca exercises option to buy an obesity startup

<figure><div><img src="https://imgproxy.divecdn.com/3-9P49KCrlRGe6xhfhkhh6gwLyPKxhxZ8qnm4B-ZxSg/g:nowe:0:158/c:2000:1129/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTYwMDg5NDkzLmpwZw==.webp" /></div></figure><p>The pharma giant disclosed in an earnings report that it paid $170 million up front to acquire SixPeaks&nbsp;Bio, a weight loss-focused startup it helped launch last year.</p>